TITLE

Synbiotic therapy (Bifidobacterium Iongum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial

AUTHOR(S)
Furrie, E.; Macfarlane, S.; Kennedy, A.; Cummings, J. H.; Walsh, S. V.; O'neil, D. A.; Macfarlane, G. T.
PUB. DATE
February 2005
SOURCE
Gut;Feb2005, Vol. 54 Issue 2, p242
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background and aims: Ulcerative colitis (UC) is an acute and chronic inflammatory disease of the large bowel with unknown aetiology. The immune response against normal commensal microorganisms is believed to drive inflammatory processes associated with UC. Therefore, modulation of bacterial communities on the gut mucosa, through the use of probiotics and prebiotics, may be used to modify the disease state. Methods: A synbiotic was developed for use in UC patients combining a probiotic, Bifidobacterium longum, isolated from healthy rectal epithelium, and a prebiotic (Synergy 1), a preferential immunoligofructose growth substrate for the probiotic strain. Treatment was employed in a double blinded randomised controlled trial using 18 patients with active UC for a period of one month. Clinical status was scored and rectal biopsies were collected before and after treatment, and transcription levels of epithelium related immune markers were measured. Results: Sigmoidoscopy scores (scale 0-6) were reduced in the test group (start 4.5 (1.4), end 3.1 (2.5)) compared with placebo (start 2.6 (2.1), end 3.2 (2.2)) (p = 0.06). mRNA levels for human beta defensins 2, 3, and 4, which are strongly upregulated in active UC, were significantly reduced in the test group after treatment (p = 0.016, 0.038, and 0.008, respectively). Tumour necrosis factor a and interleukin 1 a, which are inflammatory cytokines that drive inflammation and induce defensin expression, were also significantly reduced after treatment (p =0.018 and 0.023, respectively). Biopsies in the test group had reduced inflammation and regeneration of epithelial tissue. Conclusions: Short term synbiotic treatment of active UC resulted in improvement of the full clinical appearance of chronic inflammation in patients receiving this therapy.
ACCESSION #
16163551

 

Related Articles

  • Investigation of Inflammation and Tissue Patterning in the Gut Using a Spatially Explicit General-Purpose Model of Enteric Tissue (SEGMEnT). Cockrell, Chase; Christley, Scott; An, Gary // PLoS Computational Biology;Mar2014, Vol. 10 Issue 3, p1 

    The mucosa of the intestinal tract represents a finely tuned system where tissue structure strongly influences, and is turn influenced by, its function as both an absorptive surface and a defensive barrier. Mucosal architecture and histology plays a key role in the diagnosis, characterization...

  • Change in the Extent of Colonoscopic and Histological Involvement in Ulcerative Colitis Over Time. Moum, Bjørn; Ekbom, Anders; Vatn, Morten H.; Elgjo, Kjell // American Journal of Gastroenterology;Jun1999, Vol. 94 Issue 6, p1564 

    OBJECTIVE: Colonoscopy has replaced barium enema as the method for determining the extent of disease in patients with ulcerative colitis (UC). Normally, the extent of disease is determined by direct visualization of the mucosa, but biopsies are also used with increasing frequency. Very little is...

  • Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. Kobori, Ayako; Yagi, Yuhki; Imaeda, Hirotsugu; Ban, Hiromitsu; Bamba, Shigeki; Tsujikawa, Tomoyuki; Saito, Yasuharu; Fujiyama, Yoshihide; Andoh, Akira // Journal of Gastroenterology;Oct2010, Vol. 45 Issue 10, p999 

    Background : Interleukin (IL)-33 is a cytokine belonging to the IL-1 family. IL-33 has been shown to elicit a Th2-like cytokine response in immune cells. In this study, we investigated IL-33 expression in the inflamed mucosa of patients with inflammatory bowel disease (IBD), and characterized...

  • Demonstration of Mucosal Bridging in Crohn's Colitis. Samach, Michael; Train, John; Marshak, Richard H.; Lindner, Arthur E. // American Journal of Gastroenterology;Jul1980, Vol. 74 Issue 1, p50 

    Mucosal bridges, strands of normal appearing mucosa traversing the bowel lumen from one wall to an adjacent wall, can occur in inflammatory bowel disease, usually ulcerative colitis. We report the first radiographically documented case, confirmed by colonoscopy, of multiple mucosal bridges and...

  • Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis. Nishio, Y.; Ando, T.; Maeda, O.; Ishiguro, K.; Watanabe, O.; Ohmiya, N.; Niwa, Y.; Kusugami, K.; Goto, H. // Gut;Dec2006, Vol. 55 Issue 12, p1768 

    Background: Relapse of ulcerative colitis is difficult to predict by routine colonoscopy. A high-resolution video-magnifying colonoscope with chromoscopy enables the observation of colorectal mucosal pit patterns. Aims: To investigate the association of pit patterns as assessed by magnifying...

  • Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. Torres, M. I.; Riós, A.; A. Crusius, J. Bart // World Journal of Gastroenterology;4/7/2008, Vol. 14 Issue 13, p1972 

    Although the aetiology of inflammatory bowel disease (IBD) remains unknown, the pathogenesis is gradually being unravelled, seeming to be the result of a combination of environmental, genetic, and immunological factors in which an uncontrolled immune response within the intestinal lumen leads to...

  • Interleukin-23 and Th17 Cells in the Control of Gut Inflammation. Monteleone, Ivan; Pallone, Francesco; Monteleone, Giovanni // Mediators of Inflammation;2009, Vol. 2009, Special section p1 

    Crohn's Disease and Ulcerative Colitis, the major forms of inflammatory bowel diseases (IBDs) in humans, have been traditionally associated with exaggerated and poorly controlled T helper (Th) type 1 or Th2 cell response, respectively. More recent studies have, however, shown that IBDs are also...

  • Mucosal Healing in Ulcerative Colitis: Where do we Stand? Fiorino, Gionata; Cesarini, Monica; Indriolo, Amedeo; Malesci, Alberto // Current Drug Targets;Sep2011, Vol. 12 Issue 10, p1417 

    Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation affecting the colonic mucosa, that can extend to the whole large bowel. The severity of mucosal lesions directly reflects the disease activity and severity and may be prognostic for an aggressive...

  • Histopathological Variation in UC. Wisecarver, J. L.; Thompson, Jon S. // American Journal of Gastroenterology;Jan1999, Vol. 94 Issue 1, p19 

    Provides an overview of the study "Ulcerative Colitis: Patterns of Involvement in Colo-Rectal Biopsies and Changes With Time," by C. G. Kleer and H. D. Appelman. Importance of mucosa biopsy; Occurrence of rectal sparing in ulcerative colitis.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics